Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

INSTITUTO OFTALMOLÓGICO   FUNDACIÓN DE INVESTIGACIÓN OFTALMOLÓGICA   INSTITUTO UNIVERSITARIO   FUNDACIÓN FERNÁNDEZ-VEGA  ¿Te llamamos?
Welcome to MedicalPress a Premium Medical Theme
Title Image
Estás en:  / Inicio  /  Investigación   /  A phase III, multinational, multicenter, investigator-masked, randomised, active-controlled trial, comparing the efficacy and safety of DE-130ª with Xalatan in patients with open-angle glaucoma or ocular hypertension over a 3-month period, followed by a 12 month period, followed by a 12-month follow-up with open-label DE-130A treatment
ACTUALIDAD

 

INVESTIGADOR:

Dr. Pedro Pablo Rodríguez Calvo

 RECLUTANDO 

 

A phase III, multinational, multicenter, investigator-masked, randomised, active-controlled trial, comparing the efficacy and safety of DE-130ª with Xalatan in patients with open-angle glaucoma or ocular hypertension over a 3-month period, followed by a 12 month period, followed by a 12-month follow-up with open-label DE-130A treatment


PATOLOGÍA: Pacientes con glaucoma de ángulo abierto o hipertensión ocular
TRATAMIENTO: DE-130A
CÓDIGO DE ESTUDIO: 0130A01SA
PROMOTOR: Santen